{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:47:14Z","timestamp":1794329234377,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"PhD researchers of Guangdong Medical University in 2020","award":["GDMU2020018"],"award-info":[{"award-number":["GDMU2020018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-04120-4","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:23:30Z","timestamp":1763735010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic value of lymphocyte-to-monocyte ratio for breast cancer: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Linying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-9134","authenticated-orcid":false,"given":"Changnian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"4120_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010.","journal-title":"Breast"},{"issue":"6","key":"4120_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, et al. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72(6):524\u201341. https:\/\/doi.org\/10.3322\/caac.21754.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"4120_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014617","volume":"98","author":"J Su","year":"2019","unstructured":"Su J, et al. Development of prognostic signature and nomogram for patients with breast cancer. Medicine. 2019;98(11):e14617. https:\/\/doi.org\/10.1097\/MD.0000000000014617.","journal-title":"Medicine"},{"issue":"8","key":"4120_CR4","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","volume":"28","author":"G Curigliano","year":"2017","unstructured":"Curigliano G, et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol. 2017;28(8):1700\u201312. https:\/\/doi.org\/10.1093\/annonc\/mdx308.","journal-title":"Ann Oncol"},{"issue":"12","key":"4120_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0305-0","volume":"31","author":"HQ Ying","year":"2014","unstructured":"Ying HQ, et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol. 2014;31(12):305. https:\/\/doi.org\/10.1007\/s12032-014-0305-0.","journal-title":"Med Oncol"},{"issue":"6","key":"4120_CR6","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3892\/ol.2019.10966","volume":"18","author":"J Huszno","year":"2019","unstructured":"Huszno J, Kolosza Z. Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients. Oncol Lett. 2019;18(6):6275\u201383. https:\/\/doi.org\/10.3892\/ol.2019.10966.","journal-title":"Oncol Lett"},{"issue":"49","key":"4120_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005540","volume":"95","author":"W Song","year":"2016","unstructured":"Song W, et al. Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: a meta-analysis. Medicine. 2016;95(49):e5540. https:\/\/doi.org\/10.1097\/MD.0000000000005540.","journal-title":"Medicine"},{"issue":"1","key":"4120_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5051-9","volume":"18","author":"W Goto","year":"2018","unstructured":"Goto W, et al. Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer. BMC Cancer. 2018;18(1):1137. https:\/\/doi.org\/10.1186\/s12885-018-5051-9.","journal-title":"BMC Cancer"},{"issue":"11","key":"4120_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111886","volume":"9","author":"XJ Ni","year":"2014","unstructured":"Ni XJ, et al. An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy. PLoS ONE. 2014;9(11):e111886. https:\/\/doi.org\/10.1371\/journal.pone.0111886.","journal-title":"PLoS ONE"},{"key":"4120_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2018.03.008","volume":"481","author":"RJ Hu","year":"2018","unstructured":"Hu RJ, Ma JY, Hu G. Lymphocyte-to-monocyte ratio in pancreatic cancer: prognostic significance and meta-analysis. Clin Chim Acta. 2018;481:142\u20136. https:\/\/doi.org\/10.1016\/j.cca.2018.03.008.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4120_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6157-4","volume":"19","author":"KJ Li","year":"2019","unstructured":"Li KJ, et al. Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy. BMC Cancer. 2019;19(1):1004. https:\/\/doi.org\/10.1186\/s12885-019-6157-4.","journal-title":"BMC Cancer"},{"issue":"2","key":"4120_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/15384047.2019.1680057","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng Y, et al. Low pretreatment lymphocyte\/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients. Cancer Biol Ther. 2020;21(2):189\u201396. https:\/\/doi.org\/10.1080\/15384047.2019.1680057.","journal-title":"Cancer Biol Ther"},{"key":"4120_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.650980","volume":"11","author":"Y Yin","year":"2021","unstructured":"Yin Y, et al. Prognostic value of pretreatment lymphocyte-to-monocyte ratio and development of a nomogram in breast cancer patients. Front Oncol. 2021;11:650980. https:\/\/doi.org\/10.3389\/fonc.2021.650980.","journal-title":"Front Oncol"},{"issue":"3","key":"4120_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10549-022-06601-8","volume":"193","author":"D Kim","year":"2022","unstructured":"Kim D, et al. RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis. Breast Cancer Res Treat. 2022;193(3):637\u201347. https:\/\/doi.org\/10.1007\/s10549-022-06601-8.","journal-title":"Breast Cancer Res Treat"},{"issue":"28","key":"4120_CR15","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1200\/JCO.2008.18.9498","volume":"27","author":"HK Jensen","year":"2009","unstructured":"Jensen HK, et al. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol. 2009;27(28):4709\u201317. https:\/\/doi.org\/10.1200\/JCO.2008.18.9498.","journal-title":"J Clin Oncol"},{"key":"4120_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040826","author":"SR Kim","year":"2019","unstructured":"Kim SR, et al. Effect of red, processed, and white meat consumption on the risk of gastric cancer: an overall and dose(-)response meta-analysis. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11040826.","journal-title":"Nutrients"},{"issue":"6","key":"4120_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025.","journal-title":"Cell"},{"issue":"22","key":"4120_CR18","doi-asserted-by":"publisher","first-page":"31926","DOI":"10.18632\/oncotarget.7876","volume":"7","author":"L Gu","year":"2016","unstructured":"Gu L, et al. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget. 2016;7(22):31926\u201342. https:\/\/doi.org\/10.18632\/oncotarget.7876.","journal-title":"Oncotarget"},{"issue":"7203","key":"4120_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344. https:\/\/doi.org\/10.1038\/nature07205.","journal-title":"Nature"},{"issue":"11","key":"4120_CR20","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","volume":"10","author":"Q Yang","year":"2020","unstructured":"Yang Q, et al. The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy. Acta Pharm Sin B. 2020;10(11):2156\u201370. https:\/\/doi.org\/10.1016\/j.apsb.2020.04.004.","journal-title":"Acta Pharm Sin B"},{"key":"4120_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101355","volume":"18","author":"X Meng","year":"2022","unstructured":"Meng X, et al. Correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer. Transl Oncol. 2022;18:101355. https:\/\/doi.org\/10.1016\/j.tranon.2022.101355.","journal-title":"Transl Oncol"},{"key":"4120_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.566511","volume":"10","author":"I Larionova","year":"2020","unstructured":"Larionova I, et al. Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers. Front Oncol. 2020;10:566511. https:\/\/doi.org\/10.3389\/fonc.2020.566511.","journal-title":"Front Oncol"},{"issue":"3","key":"4120_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","volume":"25","author":"A Mantovani","year":"2006","unstructured":"Mantovani A, et al. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev. 2006;25(3):315\u201322. https:\/\/doi.org\/10.1007\/s10555-006-9001-7.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"4120_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.mpa.0000188305.90290.50","volume":"32","author":"P Fogar","year":"2006","unstructured":"Fogar P, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006;32(1):22\u20138. https:\/\/doi.org\/10.1097\/01.mpa.0000188305.90290.50.","journal-title":"Pancreas"},{"issue":"2","key":"4120_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jtcvs.2008.05.046","volume":"137","author":"KM Sarraf","year":"2009","unstructured":"Sarraf KM, et al. Neutrophil\/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137(2):425\u20138. https:\/\/doi.org\/10.1016\/j.jtcvs.2008.05.046.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4120_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-64","volume":"11","author":"J Kitayama","year":"2011","unstructured":"Kitayama J, et al. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. BMC Cancer. 2011;11:64. https:\/\/doi.org\/10.1186\/1471-2407-11-64.","journal-title":"BMC Cancer"},{"issue":"5","key":"4120_CR27","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00280-011-1610-3","volume":"68","author":"N Ceze","year":"2011","unstructured":"Ceze N, et al. Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother Pharmacol. 2011;68(5):1305\u201313. https:\/\/doi.org\/10.1007\/s00280-011-1610-3.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4120_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025.","journal-title":"Immunity"},{"issue":"4","key":"4120_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2020.03.021","volume":"37","author":"O Demaria","year":"2020","unstructured":"Demaria O, Vivier E. Immuno-oncology beyond tils: unleashing TILCs. Cancer Cell. 2020;37(4):428\u201330. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.021.","journal-title":"Cancer Cell"},{"issue":"8","key":"4120_CR30","first-page":"2553","volume":"8","author":"TK Hoffmann","year":"2002","unstructured":"Hoffmann TK, et al. Spontaneous apoptosis of Circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res. 2002;8(8):2553\u201362. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12171883.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4120_CR31","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/bjc.2013.508","volume":"109","author":"JP Vayrynen","year":"2013","unstructured":"Vayrynen JP, et al. Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer. 2013;109(7):1839\u201347. https:\/\/doi.org\/10.1038\/bjc.2013.508.","journal-title":"Br J Cancer"},{"key":"4120_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.suronc.2019.03.003","volume":"29","author":"Y Sang","year":"2019","unstructured":"Sang Y, et al. Langer\u2019s axillary arch lymph node metastasis in breast cancer patients: a prospective clinical study. Surg Oncol. 2019;29:48\u201352. https:\/\/doi.org\/10.1016\/j.suronc.2019.03.003.","journal-title":"Surg Oncol"},{"issue":"3","key":"4120_CR33","first-page":"s947","volume":"7","author":"G Dworacki","year":"2001","unstructured":"Dworacki G, et al. Decreased zeta chain expression and apoptosis in CD3\u2009+\u2009peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res. 2001;7(3):s947\u201357. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11300496.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4120_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1189\/jlb.0311177","volume":"91","author":"JI Youn","year":"2012","unstructured":"Youn JI, et al. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol. 2012;91(1):167\u201381. https:\/\/doi.org\/10.1189\/jlb.0311177.","journal-title":"J Leukoc Biol"},{"issue":"9","key":"4120_CR35","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13(9):1050\u20139. https:\/\/doi.org\/10.1038\/nm1622.","journal-title":"Nat Med"},{"issue":"18","key":"4120_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018755","volume":"99","author":"Y Deng","year":"2020","unstructured":"Deng Y, et al. The combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients with resected breast cancer. Medicine (Baltimore). 2020;99(18):e18755. https:\/\/doi.org\/10.1097\/MD.0000000000018755.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"4120_CR37","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/annonc\/mdu112","volume":"25","author":"S Loi","year":"2014","unstructured":"Loi S, et al. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Ann Oncol. 2014;25(8):1544\u201350. https:\/\/doi.org\/10.1093\/annonc\/mdu112.","journal-title":"Ann Oncol"},{"issue":"5","key":"4120_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177137","volume":"12","author":"H Takeuchi","year":"2017","unstructured":"Takeuchi H, et al. Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer. PLoS ONE. 2017;12(5):e0177137. https:\/\/doi.org\/10.1371\/journal.pone.0177137.","journal-title":"PLoS ONE"},{"issue":"4","key":"4120_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrclinonc.2015.215","volume":"13","author":"P Savas","year":"2016","unstructured":"Savas P, et al. Clinical relevance of host immunity in breast cancer: from TILs to the clinic. Nat Rev Clin Oncol. 2016;13(4):228\u201341. https:\/\/doi.org\/10.1038\/nrclinonc.2015.215.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4120_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05508-1","volume":"150","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Expression analysis of lymphocyte subsets and lymphocyte-to-monocyte ratio: reveling immunosuppression and chronic inflammation in breast cancer. J Cancer Res Clin Oncol. 2024;150(1):28. https:\/\/doi.org\/10.1007\/s00432-023-05508-1.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"4120_CR41","doi-asserted-by":"publisher","first-page":"9037","DOI":"10.1007\/s13277-016-4793-8","volume":"37","author":"J He","year":"2016","unstructured":"He J, et al. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer. Tumour Biol. 2016;37(7):9037\u201343. https:\/\/doi.org\/10.1007\/s13277-016-4793-8.","journal-title":"Tumour Biol"},{"key":"4120_CR42","doi-asserted-by":"publisher","first-page":"782383","DOI":"10.3389\/fonc.2021.782383","volume":"11","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, et al. Prognostic evaluation of Metastasis-Related Lymphocyte\/Monocyte ratio in stage \u2160-\u2162 breast cancer receiving chemotherapy. Front Oncol. 2021;11:782383. https:\/\/doi.org\/10.3389\/fonc.2021.782383.","journal-title":"Front Oncol"},{"issue":"5","key":"4120_CR43","first-page":"3233","volume":"14","author":"D Song","year":"2022","unstructured":"Song D, Li X, Zhang X. Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients. Am J Transl Res. 2022;14(5):3233\u20139.","journal-title":"Am J Transl Res"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-04120-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-04120-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:23:31Z","timestamp":1763735011000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-04120-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4120"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-04120-4","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"569"}}